| Cat. No. |
Product Name |
Information |
| PC-60729 |
AM-1241
CB2 agonist
|
AM-1241 is a potent, selective cannabinoid receptor CB2 agonist with Ki of 7.1 nM, >80-fold selectivity over CB1 receptors in radioligand binding assay. |
| PC-60728 |
GW405833 hydrochloride
CB2 agonist
|
GW405833 hydrochloride is a potent, selective cannabinoid receptor CB2 agonist with Ki of 3.6 nM, 1200-fold selectivity over CB1. |
| PC-60146 |
Olorinab
CB2 agonist
|
Olorinab (APD371) is a potent, selective and orally available CB2 cannabinoid receptor agonist with EC50 of 6.2 nM. |
| PC-60086 |
AM-6538
CB1 antagonist
|
AM-6538 (AM6538) is a potent, selective cannabinoid receptor CB1 antagonist with Ki of 5.1 nM.. |
| PC-45531 |
JD-5037
CB1 antagonist
|
JD-5037 is a potent, selective and peripherally restricted cannabinoid-1 (CB1) receptor blocker with IC50 of 2 nM, does not inhibit CB2 receptor (IC50>1000 nM). |
| PC-42171 |
Bay 59-3074
CB1/CB2 agonist
|
Bay 59-3074 is a potent, selective cannabinoid CB1/CB2 receptor partial agonist with Ki of 48.3, and 45.5 nM for human CB1 and human CB2 receptors, respectively. |
| PC-42063 |
Taranabant
CB1 inverse agonist
|
Taranabant (MK-0364) is a potent, selective and orally active cannabinoid-1 receptor (CB1R) inverse agonist with IC50 of 2.8 nM, Ki of 0.13 nM. |
| PC-42723 |
Otenabant
CB1 antagonist
|
Otenabant (CP-945598) is a potent, and selective CB1 receptor antagonist with Ki of 0.7 nM/0.12 nM in binding and functional assays respectively. |
| PC-25525 |
BI-5756
CETP inhibitor, CB1 agonist
|
BI-5756 is a cholesteryl ester transfer protein (CETP) inhibitor, also is a potent agonist of cannabinoid receptor 1 (CB1R, CB1) with IC50 of 0.966 uM in cell-based radioligand binding assay using CP55940. |
| PC-25356 |
ISAM-CG557
CB2 receptor agonist
|
ISAM-CG557 is a potent, selective, and functionally biased CB2 receptor (CB2R) agonist with binding Ki of 54.6 nM, with negligible binding to CB1R, shows strongly biased toward MAPK signaling. |
| PC-25116 |
CB1 receptor antagonist QD13
CB1 antagonist
|
CB1 receptor antagonist QD13 is a selective antagonist cannabinoid type 1 (CB1) receptor (CB1R), effectively blocks the receptor activation by the agonists. |
| PC-25022 |
Selonabant
CB1R antagonist
|
Selonabant (ANEB-001, V24343) is potent, selective cannabinoid type 1 receptor (CB1, CB1R) antagonist. |
